Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]1095Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]1771Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]2521Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O]Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-405012Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-452247Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-515699Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-524088Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-534945Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-561128Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-579118Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-580124Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-581600Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-583882Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-636638Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-650952Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-976526Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+CL)-Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]2760Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O]Peak areaPAK Untreated
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+1140Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+1229Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+3593Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGLUCOSE (CAS# 50-99-7); (M+NA)+Peak areaPAK Untreated

Return to search page
  logo